Professor of First Band of Pharmacology

EDUCATION and CAREER
Since 2001 to 2025: Full Professor of Pharmacology, University of Parma, Italy. 2004. Visiting Professor (1 month) with an NIH grant at the Joseph Stokes Jr. Research Inst. Children's Hospital of Philadelphia (USA). 1992-2001: Associated Professor of Pharmacology, University of Parma, Italy. 1988-1992: Research fellow, University of Milan, Italy. 1988: PhD in Experimental medicine, University of Milan, Italy. 1984-1988: Instructor and visiting scientist, Baylor College of Medicine, Department of Medicine in Houston (TX, USA). 1979-1984: Research fellow, University of Milan, Italy

RESEARCH INTEREST
Physiopathology and pharmacology of cholesterol homeostasis for the prevention and treatment of chronic and degenerative diseases.

MEETINGS
Participation to several national and international scientific meetings, including invited lecture. Part of the Organization committee for several national and international meetings and workshops. Steering committes of: European Lipoprotein Club (2007-2010), Italian Society for Atherosclerosis Study (2011-2013), European Cooperation in Science and Technology (2010-2013), President of the Emilia Romagna section of Italian Society for Atherosclerosis Study (2004-2006), President of the Emilia Romagna section of Italian Society of Pharmacology (from 2017).

PROJECTS (last 6 years)
2022 Project financed by European Union – NextGenerationEU (PNRR-Mnesys) - component of critical mass; 2022 Project financed by the Italian Ministry of University and Research (PRIN) - Responsible of Operative Unit. 2021: Project funded by the University of Parma – PI. 2019 Project founded by Amgen Inc – PI.
Other grants: Scientific responsible for grants from Hoffman La-Roche (2007), Chiesi Farmaceutici (2009, 2018 and 2022), Circomed AG (2006), Merck S&D (2007 and 2010), Rottapharm (2014), AkademyPharma (2017), Chiesi Farmaceutici (2020 and 2022). Additional fundings from: Fournier, Glaxo, Recordati, Sigma Tau, Kowa, Hoffman LaRoche, Sienabiotech, Astrazenaca, Chiesi Farmaceutici, Circomed AG, Merck S&D, Rottapharm, AkademyPharma, University of Parma, Spiner, INRC, Fondazione Cariparma.

BIBLIOMETRIC INDEXES
Author of 182 peer reviewed-publications; H-Index: 46 (Scopus); Total citations; 7302